RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,000 | +85.2% | 26,165 | +80.6% | 0.00% | – |
| Q2 2023 | $108,000 | +103.8% | 14,489 | +83.2% | 0.00% | – |
| Q1 2023 | $53,000 | -69.2% | 7,908 | -64.7% | 0.00% | – |
| Q4 2022 | $172,000 | +719.0% | 22,409 | +1051.0% | 0.00% | – |
| Q3 2022 | $21,000 | +162.5% | 1,947 | +92.4% | 0.00% | – |
| Q2 2022 | $8,000 | -84.3% | 1,012 | -85.7% | 0.00% | – |
| Q1 2022 | $51,000 | -88.0% | 7,081 | -71.5% | 0.00% | – |
| Q4 2021 | $425,000 | +553.8% | 24,803 | +770.6% | 0.00% | – |
| Q3 2021 | $65,000 | +22.6% | 2,849 | +97.2% | 0.00% | – |
| Q2 2021 | $53,000 | – | 1,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
| MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
| MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
| Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
| ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
| HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
| Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
| Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |